This year we have to do more than just rely on the flu vaccine. Avoiding the flu plus COVID-19 catastrophe is contingent on the US widely embracing public health guidance of wearing masks, meticulous hand hygiene and social distancing.
Many are bracing for an unbelievably bad winter with the flu plus COVID-19 teaming up to devastate our population. Whether or not this happens is up to us. Many feel we can blunt this dire warning by encouraging vaccination. However, I would assert that the vaccine this year may be problematic, but we can devastate the flu virus through wearing masks and social distancing. If we do not widely embrace this public health intervention, the flu virus may team up with coronavirus disease 2019 (COVID-19) and devastate us. Here is why.
Kevin Kavanagh, MD
Unlike the United States, many countries in the Southern Hemisphere have embraced the wearing of masks and are taking SARS-CoV-2 very seriously. SARS-CoV-2 is very infectious with an R0 of 5.7. These interventions have certainly blunted this epidemic but in many areas the epidemic still rages. However, these same interventions are effective in preventing the spread of the flu. The flu is much less infective with an R0 of 1.3. In other words, these interventions may slow down, but not stop SARS-CoV-2 but they may well devastate the flu virus. And this is what appears to have happened this spring in the United States and in the Southern Hemisphere.
If one looks at the data from the CDC, the flu became almost nonexistent in the United States by the end of March, with a very steep drop-off in cases.
Centers for Disease Control and Prevention
The World Health Organization (WHO) data from the Southern Hemisphere is even more surprising. Summer is their peak Flu season. But unlike previous years no viral specimens were submitted to the WHO from many countries during the Summer months.
World Health Organization
Last year Chile had 20,949 cases, this year there were only 1134. Claudia Cortés, MD, told the Wall Street Journal: “We were surprised by the decline in the other viruses like influenza. We never dreamed it would practically disappear.”
With both the reduction in international travel and the reduced specimens submitted to the WHO from the Southern Hemisphere, it may be difficult to predict which antigens to incorporate in the United States’ vaccine. Flu vaccines often are not truly effective in stopping the disease, but this year vaccine production may be problematic.
Thus, this year we have to do more than just rely on the flu vaccine. Avoiding the flu plus COVID-19 catastrophe is contingent on the US widely embracing public health guidance of wearing masks, meticulous hand hygiene and social distancing, for which we are a long way from doing. Even some of our elected officials are still downplaying the seriousness of this virus and advocating only those at high risk to wear masks, to protect the wearer. And, of course, we all need the added protection of getting a flu vaccination.
Healing With Algorithms: AI's Impact on Epidemiology and Infection Control
April 2nd 2024Media in the US presents AI as both beneficial and risky. Positive coverage shows AI's potential through virtual assistants like Siri, while cautionary tales warn of misuse like misinformation and deepfakes. How does all this work in health care?
Four Years After COVID-19: What Has the Infection Prevention Community Learned?
March 15th 2024Four years ago today, March 15, 2020, the COVID-19 lockdown began, and since then, the world has undergone significant changes. It has been a terrifying experience for everyone, especially for the infection prevention community, both within and outside of the health care sector. However, a crucial question remains unanswered: What has the infection prevention community learned from this pandemic, and where does it go from here?
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.